Patent classifications
B01J2231/40
Targeted, metal-catalyzed fluorination of complex compounds with fluoride ion via decarboxylation
Methods of preparing fluorinated compounds by carboxylative fluorination using fluoride are contained herein. Fluorinated compounds are provided. Methods of using fluorinated compounds are contained herein.
BIOSENSOR BASED ON TRITITANIUM DICARBIDE TWO-DIMENSIONAL METAL CARBIDE CATALYZED LUMINOL ELECTROGENERATED CHEMILUMINESCENCE PROBE AND PREPARATION METHOD
An electrogenerated chemiluminescence (ECL) probe is based on trititanium dicarbide two-dimensional (2D) metal carbide catalyzed luminol and a preparation method. The biosensor includes the probe and the electrode of the biosensor, wherein the probe includes the Ti.sub.3C.sub.2 MXenes nanosheets, a linker molecule and a bio-recognition molecule 1; the Ti.sub.3C.sub.2 MXenes nanosheets are linked with the linker molecule by electrostatic adsorption; the linker molecule is linked with the bio-recognition molecule 1 by an amide group, contains a primary or secondary amine group, and presents positive potential in water; the bio-recognition molecule 1 is a single-stranded DNA sequence 1 having a carboxyl group at the 5′ end, and a CD63 protein on exosomes is recognized by the single-stranded DNA sequence 1. It was found for the first time that Ti.sub.3C.sub.2 MXenes can improve the ECL signal of luminol, the Ti.sub.3C.sub.2 MXenes could be applicable to the ECL probe.
Catalyst, method for forming amide bond, and method for producing amide compound
A catalyst represented by General Formula (1) below: ##STR00001## where in the General Formula (1), R.sup.1 to R.sup.14 each independently represent a hydrogen atom or a substituent.
Method for the preparation of a synthetic faujasite material comprising monodisperse nanoparticles composed of single nanocrystals
The present invention relates to a method for the preparation of faujasite nanocrystals, to faujasite nanocrystals, to a method for the preparation of a stable colloidal suspension of faujasite nanocrystals, to a stable colloidal suspension of faujasite nanocrystals, and to the use of said faujasite nanocrystals and said stable colloidal suspension of faujasite nanocrystals in various applications.
PROCESS FOR PREPARING BTK INHIBITORS
Methods for preparing the Bruton's Tyrosine Kinase (BTK) inhibitor compound 2-{3-hydroxymethyl-1-methyl-5-[5-((S)-2-methyl-4-oxetan-3-yl-piperazin-1-yl)-pyridin-2-ylamino]-6-oxo-1,6-dihydro-[3,4]bipyridinyl-2-yl}-7,7-dimethyl-3,4,7,8-tetrahydro-2H,6H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1-one are provided. Methods for preparing tricyclic lactam compounds are also provided.
Process for the preparation of deuterated ethanol from D.SUB.2.O
The invention relates to a process for the preparation of a deuterated ethanol from ethanol, D.sub.2O, a ruthenium catalyst, and a co-solvent.
METHODS OF CONTROLLING SURFACE TENSION
Reactor liquids, compositions, and methods of forming acetic acid, which may reduce catalyst loss. The reactor liquids and compositions may include, and the methods may use, a tri-aliphatic hydrocarbyl phosphine oxide. The carbonylation catalyst used in the methods may include rhodium. A composition comprising: acetic acid; water; and at least one tri-aliphatic hydrocarbyl phosphine oxide; wherein the acetic acid is present in the composition at an amount of about 60% to about 80%, by weight, based on the weight of the composition; wherein the water is present in the composition at an amount of about 0.1% to about 6%, by weight, based on the weight of the composition; and wherein the at least one tri-aliphatic hydrocarbyl phosphine oxide is present in the composition at an amount of about 2% to about 20%, by weight, based on the weight of the composition.
Catalyst composition for a producing process of an unsaturated carboxylic acid salt and its derivatives from carbon dioxide and olefin
This invention relates to a catalyst composition for a producing process of an unsaturated carboxylic acid salt and its derivatives from carbon dioxide and olefin, wherein the catalyst composition in the present invention has been proved to be effective in catalyzing the carboxylation of carbon dioxide and olefin, wherein said catalyst composition comprises: a) a palladium metal complex as shown in structure (I); ##STR00001## wherein, R.sup.1, R.sup.2, R.sup.3, and R.sup.4 independently represents a group selected from hydrogen atom, halogen atom, alkyl group, alkyl halide group, alkoxy group, amine group, optionally from alkenyl group, alkynyl group, phenyl group, benzyl group, or cylic hydrocarbon group comprising hetero atom; R.sup.5 represents group selected from alkyl group or phenyl group; b) a ligand selected from organophosphorus compound; c) a base selected from sodium tert-butoxide, sodium isopropoxide, sodium 2,6-dimethylphenolate, sodium 2,6-difluorophenolate, sodium 2-methylphenolate, or sodium 2-fluorophenol); and d) a reducing agent.
Hydrocarbon conversion using UZM-50
A new aluminosilicate zeolite designated UZM-50, methods of making the zeolite, and its use as a catalyst in hydrocarbon conversion processes are described. This zeolite is represented by the empirical formula:
M.sup.+.sub.mR.sub.rAl.sub.1xE.sub.xSi.sub.yO.sub.z
where M is selected from the group consisting of hydrogen, sodium, potassium, magnesium, calcium or combinations thereof, R is the organic structure directing agent or agents derived from reactants R1 and R2 where R1 is an amine essentially incapable of undergoing pyramidal inversion and having 7 or fewer carbon atoms, and R2 is a dihaloalkane, and E is an element selected from the group consisting of gallium, iron, boron and mixtures thereof. UZM-50 has utility in various hydrocarbon conversion reactions such as conversion of an aromatic molecule to another aromatic molecule.
Process for preparing BTK inhibitors
Methods for preparing the Bruton's Tyrosine Kinase (BTK) inhibitor compound 2-{3-hydroxymethyl-1-methyl-5-[5-((S)-2-methyl-4-oxetan-3-yl-piperazin-1-yl)-pyridin-2-ylamino]-6-oxo-1,6-dihydro-[3,4]bipyridinyl-2-yl}-7,7-dimethyl-3,4,7,8-tetrahydro-2H,6H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1-one are provided. Methods for preparing tricyclic lactam compounds are also provided.